Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gustotoxicity of bleomycin.

N K Soni, P Chatterji

    ORL; Journal for Oto-Rhino-Laryngology and Its Related Specialties
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Bleomycin treatment in advanced cancer patients can cause temporary taste changes. Most patients recover normal taste sensation within 10-12 weeks after stopping the drug.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Association of Physicians of India Consensus Recommendations for Vonoprazan in Management of Acid Peptic Disorders.

    The Journal of the Association of Physicians of India·2025
    Same author

    Common electrolyte imbalance, uncommon cause.

    Cleveland Clinic journal of medicine·2025
    Same author

    Uttar Pradesh Association of Physicians of India Position Statement: Betel Quid (Paan) and Diabetes.

    The Journal of the Association of Physicians of India·2019
    Same author

    Uttar Pradesh Association of Physicians of India Position Statement: Tobacco Use and Metabolic Syndrome.

    The Journal of the Association of Physicians of India·2018
    Same author

    Facial Cellulitis: A Study of 55 Cases; from February 1932 to August 1936.

    The Indian medical gazette·2017
    Same author

    An Unusual -large Sized Rhinophyma.

    Indian journal of dermatology, venereology and leprology·2017

    Area of Science:

    • Oncology
    • Pharmacology
    • Sensory Science

    Background:

    • Bleomycin is a chemotherapy agent used for various advanced malignancies.
    • Chemotherapy-induced taste alterations (dysgeusia) are a known side effect impacting patient quality of life.
    • Understanding the incidence and recovery of taste abnormalities is crucial for patient management.

    Purpose of the Study:

    • To investigate the incidence of taste abnormality in patients with advanced malignancy treated with bleomycin.
    • To determine the duration of taste impairment and recovery time after bleomycin discontinuation.
    • To explore the potential mechanisms underlying bleomycin-induced gustotoxicity.

    Main Methods:

    • Prospective assessment of 50 patients with advanced malignancy receiving bleomycin therapy.

    Related Experiment Videos

  • Systematic evaluation of taste function and reported taste disturbances.
  • Follow-up assessment of gustatory function after cessation of bleomycin treatment.

    • Main Results:

    • 5 out of 50 patients (10%) experienced taste impairment during bleomycin therapy.
    • Gustatory sense normalized in all affected patients within 10-12 weeks post-treatment.
    • No severe or persistent taste abnormalities were reported.

    Conclusions:

    • Bleomycin can induce a 10% incidence of temporary taste abnormality in advanced cancer patients.
    • Taste function is generally reversible within 10-12 weeks after bleomycin withdrawal.
    • Further research into the pathophysiology of bleomycin gustotoxicity is warranted.